Synthesis and antitumor activities of novel 4-morpholinothieno[3,2-d]pyrimidine derivatives

Kaizhen Song , Junjie Ma , Xiao Wang , Ping Gong , Yanfang Zhao

Chemical Research in Chinese Universities ›› 2014, Vol. 30 ›› Issue (1) : 75 -81.

PDF
Chemical Research in Chinese Universities ›› 2014, Vol. 30 ›› Issue (1) : 75 -81. DOI: 10.1007/s40242-013-3281-6
Article

Synthesis and antitumor activities of novel 4-morpholinothieno[3,2-d]pyrimidine derivatives

Author information +
History +
PDF

Abstract

A series of novel 2-hydrazinyl-4-morpholinothieno[3,2-d]pyrimidine derivatives was designed and synthesized. All of them were screened for their cytotoxic activities against large cell lung cancer(H460), colon cancer (HT-29) and adenocarcinomic lung cancer(A549) cell lines in vitro. The pharmacological results indicate that most of the target compounds show moderate to significant activities. Especially compound 17 exhibits the most potent antitumor activities against H460, HT-29 and A549 cell lines with IC50 values of 0.57, 0.45 and 1.45 μmol/L, respectively.

Keywords

2-Hydrazinyl-4-morpholinothieno[3,2-d]pyrimidine / Antitumor activity / Cytotoxic activity

Cite this article

Download citation ▾
Kaizhen Song, Junjie Ma, Xiao Wang, Ping Gong, Yanfang Zhao. Synthesis and antitumor activities of novel 4-morpholinothieno[3,2-d]pyrimidine derivatives. Chemical Research in Chinese Universities, 2014, 30(1): 75-81 DOI:10.1007/s40242-013-3281-6

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

http://www.who.int/mediacentre/factsheets/fs297/en/ (WHO Media Centre Cancer Jan. 15, 2013, last accessed: 26.03.13)

[2]

Vivanco I, Sawyers C L. Nat. Rev. Cancer, 2002, 2: 489.

[3]

Schuurbiers O C J, Kaanders J H A M, Heijden H F M, van der Dekhuijzen P N R, Oyen W J G, Bussink J. J. Thorac. Oncol., 2009, 4: 761.

[4]

Dituri F, Mazzocca A, Lupo L, Edling C E, Azzariti A, Antonaci S, Falasca M, Giannelli G. Int. J. Cancer, 2012, 130: 2505.

[5]

Folkes A J, Ahmadi K, Alderton W K, Alix S, Baker S J. J. Med. Chem., 2008, 51: 5522.

[6]

Sutherlin D P, Sampath D, Berry M, Castanedo G, Chang Z. J. Med. Chem., 2010, 53: 1087.

[7]

Sutherlin D P, Bao L, Berry M, Castanedo G, Chuckowree I. J. Med. Chem., 2011, 54: 7579.

[8]

Zhu W F, Zhai X, Li S, Cao Y Y, Gao P, Liu Y J. Chin. Chem. Lett., 2012, 23: 703.

[9]

Bravo-Altamirano K, George K M, Frantz M C, la Valle C R, Tandon M, Leimgruber S, Sharlow E R, Lazo J S, Wang Q J, Wipf P. ACS Med. Chem. Lett., 2011, 2: 154.

[10]

Babu S, Cheng Z, Reynolds M E, Savage S J, Tian Q, Yajima H. Process for Making Thienopyrimidine Compounds, US8431694, 2013.

[11]

Wallace D M, Leung S H, Senge M O, Smith K M. J. Org. Chem., 1993, 58: 7245.

[12]

Drost K J, Cava M P. J. Org. Chem., 1991, 56: 2240.

[13]

Pavia M R, Moos W H, Hershenson F M. J. Org. Chem., 1990, 55: 560.

AI Summary AI Mindmap
PDF

147

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/